Skip to main content
SpringerLink
Log in

Advantages and Disadvantages of Reformulation of Older Drugs

  • Leading Article
  • Published:
Clinical Pharmacokinetics Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  • CPMP Working Party on Efficacy of Medicinal Products. Investigation of Bioavailability and Bioequivalence. Note for Guidance III/54/89-EN, December, 1991

  • Cramer JA, Mattson RH, Prevey ML, Scheyer RD, Valinda L, et al. How often is medication taken as prescribed? Journal of the American Medical Association 261: 2373–2377, 1989

    Article  Google Scholar 

  • Fletcher A, McLoone P, Bulpitt C. Quality of life on angina therapy: a randomised controlled trial of transdermal glyceryl trinitrate against placebo. Lancet 2: 4–7, 1988

    Article  PubMed  CAS  Google Scholar 

  • Greenberg RN. Overview of patient compliance with medication dosing: a literature review. Clinical Therapeutics 6: 592–599, 1984

    PubMed  CAS  Google Scholar 

  • Jonkman JHG. Food interactions with sustained release theophylline preparations. Clinical Pharmacokinetics 16: 162–179, 1989

    Article  PubMed  CAS  Google Scholar 

  • Kleinbloesem CH, Van Brummelen P, Danhof M, Faber H, Urquhart J, et al. Rate of increase in the plasma concentration of nifedipine as a major determinant of its hemodynamic effects in humans. Clinical Pharmacology and Therapeutics 41: 26–30, 1987

    Article  PubMed  CAS  Google Scholar 

  • Kleinbloesem CH, Van Brummelen P, Van de Linde JA, Voogd PJ, Breimer DD. Nifedipine: kinetics and dynamics in healthy subjects. Clinical Pharmacology and Therapeutics 35: 742–749, 1984

    Article  PubMed  CAS  Google Scholar 

  • Leeuwenkamp OR, Visscher HW, Mensink CK, Jonkman JHG. A comparative study of the steady state pharmacokinetics of immediate-release and controlled-release diltiazem tablets. European Journal of Clinical Pharmacology, in press, 1993

    Google Scholar 

  • Manninen V, Melin H, Hartel G. Serum-digoxin concentrations during treatment with different preparations. Lancet 2: 934–935, 1971

    Article  PubMed  CAS  Google Scholar 

  • Oosterhuis B, Jonkman JHG. Significance of the reference product in bioequivalence evaluations with highly variable drugs: pharmaceutical quality, variability, biopharmaceutical characteristics. In Blume & Midha (Eds) Bio-international’ 92: bioavailability, bioequivalence and pharmacokinetic studies, Medpharm Scientific Publishers, Stuttgart, in press, 1993

    Google Scholar 

  • Prescott LF, Nimmo WS (Eds) Novel drug delivery, pp. 1–11, John Wiley & Sons, Chichester, 1989

    Google Scholar 

  • Rawlins MD. Adverse effects of novel delivery systems. In Prescott & Nimmo (Eds) Novel drug delivery, pp. 237–244, John Wiley & Sons, Chichester, 1989

    Google Scholar 

  • Reynolds JEF (Ed.) Martindale: the extra pharmacopoeia, 27th ed., Pharmaceutical Press, London, 1977

    Google Scholar 

  • Rocco MB, Barry S, Cambell S. Circadian variation of transient myocardial ischemia in patients with coronary artery disease. Circulation 75: 395–400, 1987

    Article  PubMed  CAS  Google Scholar 

  • Skelly JP. Drug regulation and novel drug delivery systems. In Prescott & Nimmo (Eds) Novel drug delivery, pp. 341–351, John Wiley & Sons, Chichester, 1989

    Google Scholar 

  • Steinijans VW, Sauter R, Böhm A, Staudiger H. Pharmacokinetic profile of a new sustained-release theophylline pellet formulation for once-daily evening administration. Arzneimittel-Forschung 38(2): 1241–1250, 1988

    PubMed  CAS  Google Scholar 

  • Stewart RB, Cluff LE. A review of medication errors and compliance in ambulant patients. Clinical Pharmacology and Therapeutics 13: 463–468, 1972

    PubMed  CAS  Google Scholar 

  • Strieker H. Superbioavailability. In Blume & Midha (Eds) Biointernational’ 92: bioavailability, bioequivalence and pharmacokinetic studies, Medpharm Scientific Publishers, Stuttgart, in press, 1993

    Google Scholar 

  • Urquhart J. Time to take our medicines seriously. Pharmaceutisch Weekblad - Scientific Edition 127: 769–776, 1992

    Google Scholar 

  • Urquhart J, Chevalley C. Impact of unrecognized dosing errors on the cost and effectiveness of pharmaceuticals. Drug Information Journal 22: 363–378, 1988

    Google Scholar 

  • Welling PG, Tse FLS, Dighe SV (Eds). Pharmaceutical bioequivalence, pp. 347–461, Marcel Dekker Inc., New York, 1991

    Google Scholar 

  • Wendt G. Marktübersicht zu Bioäquivalenzangaben von Theophyllin-retardpräparaten in Deutschland. In Blume & Krämer (Eds) Bioäquivalenzbewertung retardierter Theophyllin-fertig-arzneimittel, pp. 39–50, Govi Verlag, Frankfurt, 1990

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Pharma Bio-Research International B.V., Science Park, P.O. Box 200, NL-9470, Zuidlaren, The Netherlands

    Berend Oosterhuis &  Jan H. G. Jonkman

Authors
  1. Berend Oosterhuis
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jan H. G. Jonkman
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Oosterhuis, B., Jonkman, J.H.G. Advantages and Disadvantages of Reformulation of Older Drugs. Clin-Pharmacokinet 25, 165–171 (1993). https://doi.org/10.2165/00003088-199325030-00001

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003088-199325030-00001

Keywords

Search

Navigation